share_log

Hypera (OTCMKTS:HYPMY) Upgraded at The Goldman Sachs Group

Hypera (OTCMKTS:HYPMY) Upgraded at The Goldman Sachs Group

高盛集团对Hypera（OTCMKTS: HYPMY）进行了升级
Financial News Live ·  2022/10/21 14:31

The Goldman Sachs Group upgraded shares of Hypera (OTCMKTS:HYPMY – Get Rating) from a neutral rating to a buy rating in a research report released on Monday, The Fly reports.

高盛集团上调了股票 Hypera (OTCMKTS: HYPMY — 获取评级) The Fly报道，在周一发布的研究报告中，从中性评级到买入评级。

Hypera Trading Up 1.4 %

Hypera 交易量上涨1.4％

Hypera stock opened at $9.34 on Monday. The business's 50-day simple moving average is $8.47 and its 200-day simple moving average is $7.98. Hypera has a 52 week low of $4.63 and a 52 week high of $9.37.

Hypera股票周一开盘价为9.34美元。该公司的50天简单移动平均线为8.47美元，其200天简单移动平均线为7.98美元。Hypera的52周低点为4.63美元，创下52周高点9.37美元。

Get
得到
Hypera
Hypera
alerts:
警报：

Hypera Company Profile

Hypera 公司简介

(Get Rating)

（获取评级）

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Hypera SA作为一家制药公司在巴西运营。它提供 Adacne、Addera、apri、AmpliumG 下的处方产品，请 Celestamine、Celestone、Celestone Soluspan、Cizax、diciprax、Dirmotil Fusid、Digedrat、diprosalic、diprosone、diprosone、diprosalic、diprosone、diprosone、Diprosan、Emprol XR、Flow、Garasone、Halobex、Librox panon、moon、Lydian、macrodantin、maxSulid、milgamma、Mioflex — A、nesina、Novotram、oximax、predal、pressaliv、Quadridem、Rizi M、softalm、tacroz、tinodin、umma 和 velunid 品牌。

Featured Articles

精选文章

  • Get a free copy of the StockNews.com research report on Hypera (HYPMY)
  • Is it Time to Snack on Mondelez Stock?
  • Freeport McMoran Shares Rally Despite Weakening Copper Prices
  • Will Matador Share Price Get A Boost From Improved Credit Rating?
  • Tesla Stock Slides After Revenue Miss, Musk Maintains Optimism
  • AT&T Jumps Higher Thursday After Better-Than-Expected Q3 Results
  • 免费获取 StockNews.com 关于 Hypera (HYPMY) 的研究报告的副本
  • 是时候在 Mondelez 的股票上吃零食了吗？
  • 尽管铜价疲软，弗里波特麦克莫兰股价仍上涨
  • 信用评级的提高会提振斗牛士的股价吗？
  • 收入下降后，特斯拉股价下滑，马斯克保持乐观情绪
  • 在第三季度业绩好于预期之后，AT＆T周四上涨

Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.

接收 Hypera Daily 的新闻和收视率 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收Hypera及相关公司最新新闻和分析师评级的简明每日摘要。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发